Afanat Afatinib 40 Mg Tablet

Afanat 40 mg Tablets

Generic Name: Afatinib
Brand Name: Afanat
Strength: 40 mg
Manufacturer: Natco Pharma Ltd
Packaging Size: 28 Tablets per Box
Form: Tablet
Prescription/Non-prescription: Prescription Only
Country of Origin: Made in India

Composition:

• Active Ingredient: Afatinib 40 mg

Therapeutic Category:

• Indication: Treatment of Non-Small Cell Lung Cancer (NSCLC)

• Type of Therapy: Targeted Therapy (EGFR Tyrosine Kinase Inhibitor)

Product Overview:

Afanat 40 mg is an oral targeted cancer therapy used in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations. It belongs to the class of tyrosine kinase inhibitors (TKIs) and works by blocking the signals that encourage cancer cell growth.

International Brand Equivalents:

• Gilotrif®

• Xovoltib®

Afanat is a cost-effective alternative to these international brands and is available in 20 mg, 30 mg, and 40 mg strengths.

Dosage & Administration:

• Typically taken once daily, on an empty stomach (at least 1 hour before or 2 hours after food)

• Dosage must be determined and monitored by an oncologist

• Do not self-adjust dose without medical supervision

Key Features:

• Manufactured by Natco Pharma, a leader in oncology generics

• Targeted treatment that improves outcomes in patients with EGFR-mutated NSCLC

• Offered in convenient monthly packaging of 28 tablets

• High-quality formulation complying with international standards

• Suitable for clinical and hospital use worldwide